Supernus Pharmaceuticals, Inc. (SUPN)
48.69
-0.77
(-1.56%)
USD |
NASDAQ |
Apr 28, 16:00
48.66
-0.03
(-0.06%)
After-Hours: 20:00
Supernus Pharmaceuticals Research and Development Expense (TTM) : 104.15M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Biogen, Inc. | 1.498B |
| Corcept Therapeutics, Inc. | 254.91M |
| BridgeBio Pharma, Inc. | 451.95M |
| Cytokinetics, Inc. | 405.90M |
| Oncotelic Therapeutics, Inc. | 0.0044M |